Plastics that convert light to electricity could have a big impact
Researchers the world over are striving to develop organic solar cells that
can be produced easily and inexpensively as thin films that
could be widely used to generate electricity.
But a major obstacle is coaxing these carbon-based materials to reliably form the proper structure at the nanos...
SAFC Biosciences(R) Defines Hydrolysate Components That Enhance Chinese Hamster Ovary (CHO) Cell Line Protein Production
ST. LOUIS, July 29 /PRNewswire-FirstCall/ -- SAFC Biosciences(R), a business segment within SAFC(R), a member of the Sigma-Aldrich Group (Nasdaq: SIAL ), announced today that
it has developed a new, chemically defined cell culture supplement based on the characterization of hydrol...
Varian Medical Systems to Showcase a Wide Spectrum of New and Updated Products That Improve Radiotherapy Treatment Processes at 2009 AAPM Meeting
ANAHEIM, Calif., July 23 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR ) will showcase a wide spectrum of new and updated products that
improve and simplify the processes of radiotherapy and radiosurgery. Among the products on display will be a new version of the Ec...
Bion Announces Approval of New U.S. Patent that Broadens Protection for the Company's Livestock Waste Environmental Treatment Processes
NEW YORK, June 30 /PRNewswire-FirstCall/ -- Bion Environmental Technologies, Inc. (OTC Bulletin Board: BNET) announced today that
it was notified that
its U.S. Patent application 11/592,513 entitled "Low Oxygen Biologically Mediated Nutrient Removal" has been approved. The patent application was m...
Register to Win a Ski Weekend and Make Your Synthesis Easier with EasyMax™: the First Automated Chemistry Development Tool That Requires No Training
EasyMax™ is a small and powerful lab reactor system for the synthesis lab and synthetic organic chemist - heating and cooling without an additional cryostat. For a limited time, METTLER TOLEDO is offering a FREE TRIAL of the first automated chemistry development tool that
requires no train...
MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners
DENVER, CO, June 25 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) ( http://www.mitcanada.ca http://www.mitinvest.ca ), MIT is pleased to announce that
it has received a US$ 500,000 private placement from its Chinese partners and a new order of 200 units. This privat...
Wound Management Technologies, Inc. Announced Today That It Has Reached an Agreement in Principal to Acquire BioPharma Management Technologies, Inc.
FORT WORTH, Texas, June 16 /PRNewswire/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (WNDM.OB), announced today that
it has reached an agreement in principle to acquire BioPharma Management Technologies, Inc., a privately held biotechnology company with a pl...
New Phase 3 Data Continue to Indicate that Wyeth's Investigational 13-valent Vaccine Has the Potential to Broaden Coverage Against Pneumococcal Disease
COLLEGEVILLE, Pa., June 11 /PRNewswire-FirstCall/ -- New data from Phase 3 European clinical trials reinforce that
Wyeth's (NYSE: WYE ) investigational pneumococcal vaccine, Prevenar 13* (Pneumococcal Polysaccharide Conjugate Vaccine, 13-valent [Adsorbed]), has the potential to provide cov...
Australia: Face Mask That Kills Swine Flu Readied for Australian Pandemic Fight
HONG KONG, June 11 /PRNewswire-Asia/ -- With a four-fold increase in swine
flu cases within the last week, Filligent, the Australian-led biotech company,
is mobilizing stocks of its anti-infective BioMask to help combat the spread
of Influenza A (H1N1) across Australia. The BioMask is the firs...
New Survey Reveals That More Than Half of Rheumatoid Arthritis Patients in Europe and Canada Feel Their Disease Controls Their Lives
Three-of-Four Patients Surveyed Experience Daily Pain From Rheumatoid Arthritis Despite Current Treatment; Findings Unveiled at the European League Against Rheumatism Annual Congress of Rheumatology
COPENHAGEN, Denmark, June 10 /PRNewswire-FirstCall/ -- Results from the Rheumatoid Arthritis: ...
Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
SPRINGFIELD, Va., June 9 /PRNewswire/ -- Methuselah Foundation has identified Organovo, Inc. as a leader in the extraordinary science of bio-printing. The US Department of Health and Human Services predicts: "Within 20 years regenerative medicine will be the standard of care for replacing all tis...
Icahn Indicates That Biogen Board Refuses To Close Polls
NEW YORK, June 3 /PRNewswire/ -- Carl Icahn announced today that
Biogen is acting in its usual shareholder unfriendly way by manipulating the annual meeting of shareholders in order the prevent the votes that
have been submitted from being counted. They are doing so in order to attempt to keep tw...
Scientists create metal that pumps liquid uphill
In nature, trees pull vast amounts of water from their roots up to their leaves hundreds of feet above the ground through capillary action, but now scientists at the University of Rochester have created a simple slab of metal that
lifts liquid using the same principlebut does so at a speed that
MIT, BU engineer cellular circuits that count events
CAMBRIDGE, Mass.--MIT and Boston University engineers have designed cells that
can count and "remember" cellular events, using simple circuits in which a series of genes are activated in a specific order.
Such circuits, which mimic those found on computer chips, could be used to count the numbe...
Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452
Cytokinetics Receives Exercise Fee of $50 Million
Cytokinetics to Host a Conference Call Tuesday, May 26, 2009 at 9 AM ET
SOUTH SAN FRANCISCO, Calif. and THOUSAND OAKS, Calif., May 26 /PRNewswire-FirstCall/ -- Cytokinetics Incorporated (Nasdaq: CYTK ) and Amgen Inc. (Nasdaq: AMGN ) ...
Techne Corporation Announces That John L. Higgins has Accepted a Seat on Techne's Board
MINNEAPOLIS, May 19 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH ) today announced that
Mr. John L. Higgins has accepted a position on Techne's Board of Directors and will also serve as a member of Techne's Audit, Compensation and Nominations and Governance Committees. Mr. Higgins...
Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
VANCOUVER, May 19 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ANP) today announced that
its Quill(TM) SRS wound closure product line is now available for purchase online in the U.S. on its website at https://ecommerce.angiotech.com/Main/Home.aspx . The Quill SR...
Quark Pharmaceuticals Presented At ARVO Data Showing That PF-04523655 Enters Retinal Cells And Elicits Its Pharmacologic Effect Via Target Gene Knock-Down Without Activating TLR3
FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that
Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04...
Sandia researchers construct carbon nanotube device that can detect colors of the rainbow
LIVERMORE, Calif. Researchers at Sandia National Laboratories have created the first carbon nanotube device that
can detect the entire visible spectrum of light, a feat that
could soon allow scientists to probe single molecule transformations, study how those molecules respond to light, observe h...
CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
Technology also has potential to fight cancer, rheumatoid arthritis, as well as enhance the effectiveness of vaccines
VIENNA, Va., April 27 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM ) announced today the presentation of data at the 11th annual National Foundation of Infe...
Dr. Susan Weinschenk, Chief of Technical Staff and Services, Speaks on Neuro Web Design at 'Persuasive Technologies 2009 Conference' and 'Voices That Matter Web Design Conference'
NEW YORK, April 24 /PRNewswire/ -- Dr. Susan Weinschenk is Chief of Technical Staff and Services of Human Factors International (HFI), a global leader of user experience design services. Dr. Weinschenk recently released her latest book Neuro Web Design : What makes them click? Colleagu...
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains
H1N1 Virus-like Particle (VLP) Vaccine Candidate Based on the 1918 Spanish Influenza Strain Protected Mice and Ferrets Against the Spanish Flu and Highly Pathogenic H5N1 Bird Flu
ROCKVILLE, Md., April 14 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today reported preclini...
Connecting Materials Science With Biology, K-State Engineers Create DNA Sensors That Could Identify Cancer Using Material Only One Atom Thick
MANHATTAN, Kan., April 13 /PRNewswire-USNewswire/ -- Kansas State University engineers think the possibilities are deep for a very thin material.
Vikas Berry, assistant professor of chemical engineering, is leading research combining biological materials with graphene, a recently developed ...
Xmark Requests That Icagen Oust Its CEO and Pursue Strategic Alternatives, and Calls on Board Members to Resign
RIDGEFIELD, Conn., April 1 /PRNewswire/ -- On April 1, 2009, Xmark Opportunity Partners, LLC, the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., sent the following letter to the Board of Directors of Icagen, Inc. (Nasdaq: ICGN ).
CeNeRx BioPharma Awarded New Patent for its Innovative Compounds That Selectively Target Peripheral Cannabinoid Receptors
--By Avoiding the CNS, These Compounds May Be Free of the Side Effects Associated with Traditional Cannabinoid Compounds--
RESEARCH TRIANGLE PARK, N.C., April 1 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases o...
Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid
CORONA, Calif., March 31 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading specialty pharmaceutical company, announced today that
the United States District Court for the District of Delaware has ruled that
Watson's generic version of Concerta (methylphenidate hydroc...
Bio-Matrix Scientific Group CEO Tells Wall Street Transcript That 'Positive Cash Flow' Is Possible in '09; New Stem Cell Banking Facility Is Growth Vehicle Over the Next Two Years, Says CEO in Exclusive News Interview
SAN DIEGO, March 25 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN), told the editors of The Wall Street Transcript, a New York City financial news weekly, that
there is an excellent possibility that
the company ...
Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule
RICHMOND, Va., March 25 /PRNewswire-FirstCall/ -- Insmed Inc. (Nasdaq: INSM ), a developer of follow-on biologics (FOB) and biopharmaceuticals, today announced that
on Monday, March 23, 2009, NASDAQ issued a notice further extending the suspension of the rules requiring a minimum $1 closing bid ...
Surveyed Experts Indicate That Byetta LAR and Victoza Have Advantages Over Actos in the Treatment of Type 2 Diabetes
Byetta LAR Will Earn Decision Resources' Clinical Gold Standard Status for Type 2 Diabetes in 2012, According to a New Report from Decision Resources
WALTHAM, Mass., March 24 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and heal...
UB engineers prove that carbon nanotubes are superior to metals for electronics
BUFFALO, N.Y. -- In the quest to pack ever-smaller electronic devices more densely with integrated circuits, nanotechnology researchers keep running up against some unpleasant truths: higher current density induces electromigration and thermomigration, phenomena that
damage metal conductors and ...
Progress toward an Alzheimer's drug that saves brain cells
Leuven − VIB scientists connected to the K.U.Leuven have identified a molecule that
can form the basis for a new therapy for Alzheimer's disease. This is the first step toward a medicine that
could actually stop the progress of Alzheimer's. Existing medicines can at best limit the loss of m...
Proteomics Study Reveals That Genes Involved in Invertebrate Longevity Have Surprising Parallels in Humans.
SALT LAKE CITY, March 13 /PRNewswire/ -- Prolexys Pharmaceuticals announced today the publication of the discovery of genes that
are likely to have a role in the aging process of humans. The findings result from research on the human equivalents of proteins from simple animals which confer long l...
Photos: 'Project Runway's' Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldn't Let Psoriasis Impact Personal Style
Campaign Sponsored by Amgen and Wyeth Offers a Chance to Win a Walk on the Runway in New York City Fashion Show
NEW YORK, March 4 /PRNewswire-FirstCall/ -- Amgen and Wyeth today announced that
they have partnered with Tim Gunn, television host and fashion consultant ("Project Runway," "Ti...
Agendia Publishes Direct Evidence That MammaPrint Predicts Benefit of Chemotherapy in Breast Cancer
HUNTINGTON BEACH, California, and AMSTERDAM, February 18 /PRNewswire/ --
Agendia, a world leader in molecular cancer diagnostics, today announced that
a study demonstrating the direct predictive ability of its breast cancer
recurrence test, MammaPrint(R), has been published in Breast Cancer Re...
MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission
ORCHARD PARK, N.Y., Feb. 6 /PRNewswire-FirstCall/ -- MINRAD International,
Inc. (Amex: BUF ) -- On February 2, 2009, the Company received a notice from
NYSE Alternext US LLC (the "Exchange") stating that
the Exchange intends to
strike the common stock of the Company from the Exchange by fili...
Cancer Advances Acquires the Intellectual Property for a Suite of Products that Enhance the Immune System in Treatment of Gastric, Pancreatic, and Colorectal Cancers
DURHAM, N.C., Feb. 2 /PRNewswire/ -- Cancer Advances, Inc. (Cancer Advances), a Cato BioVentures portfolio company, announced today that
it has completed its acquisition of all the technology and intellectual property for a suite of products that
enhance the immune system for application in three ...
Domain walls that conduct electricity
BERKELEY, CA The logic and memory functions of future electronic devices could shrink dramatically to one or two nanometers (billionths of a meter) instead of the many tens of nanometers that
characterize today's most advanced elements - if a way can be found to control domain walls, the ultrath...
Rising H9N2 Influenza Replikin Count Has Doubled That of H5N1
The H9N2 strain of influenza commonly infects poultry and occasionally humans. Replikins, Ltd., using its FluForecast® software, has studied the Replikin Count® annually in each of H9N2 and its sister strain H5N1. Cyclic increases and decreases appear to be synchronous for H9N2 and H5N1...
Purdue researcher invents molecule that stops SARS
WEST LAFAYETTE, Ind. - A Purdue University researcher has created a compound that
prevents replication of the virus that
causes SARS and could lead to a treatment for the disease.
"The outbreak of SARS in 2003 led to hundreds of deaths and thousands of illnesses, and there is currently no treat...
Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
CARLSBAD, Calif., Dec. 17 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals,
Inc. (Nasdaq: ISIS ) announces the following webcast:
What: Abbott's exercise of its option to purchase Ibis Biosciences,
a subsidiary of Isis. Total acquisition price will be